期刊文献+

KLK10基因表达增强能够降低人舌癌细胞的增殖和侵袭能力 被引量:1

Enhancement of kallikrein-related paptidase 10 expression attenuates proliferation and invasiveness of human tongue cancer cells in vitro
下载PDF
导出
摘要 目的探讨人组织激肽释放酶10(KLK10)对舌癌Tca8113细胞增殖和侵袭力的影响。方法运用分子生物学技术,构建真核表达载体pIRES2-EGFP-KLK10,转染Tca8113细胞,分别用RT-PCR、Western blot检测KLK10 mRNA及蛋白表达水平。MTS细胞生长实验检测细胞增殖的变化;Transwell小室细胞侵袭实验检测细胞侵袭能力的变化。结果 pIRES2-EGFP-KLK10转染Tca8113细胞获得稳定细胞株,与空白对照组及空载体组比较,KLK10 mRNA及蛋白表达水平均明显增高,KLK10增强表达的舌癌细胞增殖和侵袭能力均明显减弱(P<0.05)。结论 KLK10表达增强能够降低人舌癌细胞的增殖和侵袭能力。KLK10基因可能成为肿瘤治疗上有前途的分子靶点。 Objective To study the effect of kallikrein-related paptidase 10 (KLK10) on the proliferation and invasiveness of human tongue cancer cell line Tca8113. Methods The eukaryotic expression vector harboring KLK10 gene (pIRES2-EGFP-KLK10) was transfected in Tca8113 cells and the stable cell lines were selected by G418 screening. The mRNA and protein expression of KLK10 in transfected Tca8113 cells were assayed by RT-PCR and Western blotting, respectively, and the proliferation and invasiveness of the cells were evaluated by MTS cell growth assay and Transwell chamber invasion experiments. Results A stable Tca8113 cell line with high KLK10 expression was obtained, which showed significantly increased mRNA and protein expression levels of KLK10 and obviously attenuated proliferation and invasiveness compared with control and empty vector-transfected cells (P〈0.05). Conclusion Enhancing KLK10 gene expression can decrease the proliferation and invasiveness of human tongue cancer cells in vitro.
出处 《南方医科大学学报》 CAS CSCD 北大核心 2012年第12期1796-1799,共4页 Journal of Southern Medical University
基金 河南大学校内科研基金重点项目(2010ZRZD02)
关键词 KLK10 TCA8113 细胞增殖 细胞侵袭 kallikrein-related paptidase 10 Tca8113 cell proliferation cell invasion
  • 相关文献

参考文献12

  • 1Liu XL, Wazer D, Watanabe K, et al. Identification of a novel serine protease-like gene, the expression of which is down- regt, lated during breast cancer progression[J]. Cancer Res, 1996, 56 (14): 3371-9.
  • 2Petraki CD, Karavana VN, Luo LY, et al. Human kallikrein 10expression in normal tissues by immunohistochemistry[J]. J Histochem Cytochem, 2002, 50(9): 1247-61.
  • 3Yousef GM, Diamandis EP. Tissue kallikreins: new players in normal and abnormal cell growth[J]. Thromb Haemost, 2003, 90 (1): 7-16.
  • 4Luo LY, Yousef G, Diamandis EE Human tissue kallikreins and testicular cancer[J]. APM1S, 2003, 111 ( 1 ): 225-32.
  • 5Goyal J, Smith KM, Cowan JM, et al. The role for NESI serine protease as a novel tumor suppressor[J]. Cancer Res, 1998, 58(21 ): 4782-6.
  • 6Kioulafa M, Kaklamanis L, Stathopoulos E, et al. Kallikrein 10 (KLKl0)methylation as a novel prognostic biomarker in early breast cancer[J]. Ann Oncol, 2009, 20(6): 1020-5.
  • 7Batra J, Tan OL, O'mara T, et al. Kallikrein-related peptidase 10 (KLKl0)expression and single nucleotide polymorphisms in ovarian cancer survival [J]. lnt J Gynecol Cancer, 2010, 20(4): 529-36.
  • 8Talieri M, Alexopoulou DK, Scorilas A, et al. Expression analysis and clinical evaluation of kallikrein-related peptidase 10(KLK10)in colorectal cancer[J]. Tumour Biol, 2011,32(4): 737-44.
  • 9Zhang Y, Bhat I, Zeng M, et al. Human kallikrein 10,a predictive marker for breast cancer[J]. Biol Chem, 2006, 387(6): 715-21.
  • 10White NM, Chow TF, Mejia-Guerrero S, et al. Three dysregulated miRNAs control kallikrein 10 expression and cell proliferation in ovarian cancer[J]. Br J Cancer, 2010, 102(8): 1244-53.

同被引文献5

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部